Sellas Life Sciences Group Inc (SLS) — Cash Flow-to-Debt Ratio
Sellas Life Sciences Group Inc (SLS) has a Cash Flow-to-Debt Ratio of -0.66x as of December 2025, meaning its operating cash flow of $-4.92 Million could theoretically repay -1% of its total liabilities ($7.47 Million) in one year. See Sellas Life Sciences Group Inc (SLS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sellas Life Sciences Group Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Sellas Life Sciences Group Inc across 19 annual periods. Also explore SLS shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sellas Life Sciences Group Inc (2007–2025)
Year-by-year debt coverage analysis for Sellas Life Sciences Group Inc. For market capitalisation and broader financial context, see SLS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.80x | $-28.39 Million | $7.47 Million | ▼ -6.9% |
| 2024 | -3.55x | $-35.40 Million | $9.97 Million | ▼ -60.5% |
| 2023 | -2.21x | $-31.41 Million | $14.20 Million | ▼ -49.6% |
| 2022 | -1.48x | $-23.81 Million | $16.09 Million | ▲ +65.4% |
| 2021 | -4.28x | $-26.02 Million | $6.08 Million | ▼ -643.1% |
| 2020 | -0.58x | $-10.42 Million | $18.09 Million | ▲ +65.7% |
| 2019 | -1.68x | $-17.64 Million | $10.52 Million | ▲ +35.6% |
| 2018 | -2.61x | $-30.42 Million | $11.67 Million | ▼ -646.2% |
| 2017 | -0.35x | $-10.99 Million | $31.46 Million | ▲ +71.1% |
| 2016 | -1.21x | $-44.91 Million | $37.15 Million | ▼ -72.3% |
| 2015 | -0.70x | $-48.16 Million | $68.63 Million | ▲ +28.9% |
| 2014 | -0.99x | $-42.87 Million | $43.43 Million | ▼ -180.3% |
| 2013 | -0.35x | $-28.91 Million | $82.09 Million | ▲ +54.3% |
| 2012 | -0.77x | $-20.96 Million | $27.23 Million | ▼ -9.5% |
| 2011 | -0.70x | $-14.67 Million | $20.86 Million | ▲ +65.4% |
| 2010 | -2.03x | $-10.26 Million | $5.05 Million | ▲ +4.8% |
| 2009 | -2.14x | $-11.77 Million | $5.51 Million | ▲ +68.5% |
| 2008 | -6.78x | $-9.43 Million | $1.39 Million | ▼ -48.4% |
| 2007 | -4.57x | $-6.05 Million | $1.32 Million | — |